US Patent Issued to Otsuka Pharmaceutical on July 28 for "Methods for dose initiation of aripiprazole treatments" (Maryland, New Jersey, Virginia Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,056, issued on July 28, was assigned to Otsuka Pharmaceutical Co. Ltd. (Tokyo).

"Methods for dose initiation of aripiprazole treatments" was invented by Matthew Harlin (Severna Park, Md.), Xiaofeng Wang (Ellicott City, Md.), Yanlin Wang (Jersey City, N.J.) and Arash Raoufinia (Mclean, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to a method of dose initiation for an aripiprazole treatment to a patient in need thereof; the patient is administered two, separate 100 to 500 mg injections of an aripiprazole intramuscular (IM) depot formulation at separate gluteal and/or deltoid injection sites, and a single dose o...